View Financial HealthGrapefruit USA 배당 및 자사주 매입배당 기준 점검 0/6Grapefruit USA 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Nov 16Grapefruit USA, Inc. announced delayed 10-Q filingOn 11/15/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 17Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/16/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/17/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 20Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery CreamGrapefruit USA, Inc. announced that its Notice of New Cannabis Product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Approval of Grapefruit’s NNCP was a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. As a result of the Health Canada Hourglass™ NNCP approval, Grapefruit can sell Hourglass THC-infused products throughout both California and Canada, which have a combined population in excess of 75 million people. Grapefruit believes its Hourglass™ THC/CBD delivery cream is a truly disruptive technology that will fundamentally change the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without exposure to the dangers of smoking and/or orally ingesting THC, CBD and other cannabinoids. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass technology enables users, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass-based products work without the health risks from smoking or orally ingesting THC and CBD.공시 • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Mar 29Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc. on March 22, 2022. Grapefruit USA, Inc. (OTCPK:GPFT) will issue a to be agreed upon number of its common shares in consideration of the Acquisition. The transaction is subject to Due Diligence Review by Diagnostic Lab Corporation, Inc., signing of a binding Letter of Intent and a Definitive Agreement. The parties will sign a binding Letter of Intent on or before April15, 2022 and will close the transaction on or before September 1, 2022.공시 • Mar 05Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP SubmissionGrapefruit USA, Inc. announced Notice of New Cannabis Product filed with Health Canada for its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Health Canada is the department of the federal government of Canada responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. On Feb. 18, 2022, Grapefruit received an inquiry from Health Canada about the composition of specific Hourglass ingredients. Grapefruit’s timely response to the inquiry was promptly accepted by Health Canada. Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology which has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and/or oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids.공시 • Feb 24Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of DirectorsGrapefruit USA, Inc. announced that its Chief Executive Officer Bradley J. Yourist has been elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’s Property Owners Association Board of Directors for a one-year term, effective immediately.공시 • Dec 07Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass™ TechnologyGrapefruit USA, Inc. announced the official launch of the world’s first patented time-release, hemp-based CBD topical cream with boosted bioavailability, made possible by its proprietary Hourglass™ technology. Hourglass™ is a unique method for staggered and discreet topical delivery of CBD. The brand-new technology, developed by Grapefruit, leverages a proprietary process that involves the grinding of CBD into nano sized particles, substantially smaller than the width of a human hair, which allows for significantly higher bioavailability and absorption. The nano-particle technology enables anyone who wants to enjoy the incredible holistic benefits of CBD to do so, both immediately and over a sustained period of up to 8-10 hours, in a discreet and convenient manner. The micro-sized vessels called “Z-Pods™”, lodge deep into human pores and follicles, persisting there, before slowly releasing CBD over an extended time period, forming what Grapefruit has dubbed the “Patchless-Patch™” system.공시 • Aug 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/17/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jun 15Grapefruit Usa, Inc. Expands its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet TinctureGrapefruit USA, Inc. (‘GPFT,’ ‘Grapefruit’ or the ‘Company’) announced that it is expanding its hemp-based cannabidiol (‘CBD’) product line with a new U.S. Department of Agriculture (‘USDA’) certified CBD pet tincture targeting two of the most common dog and cat ailments – anxiety and joint pain. Grapefruit’s new Pet 300 mg CBD hemp-based tincture is derived from USDA Certified Organic hemp, grown only in the United States. The pet CBD industry has experienced significant growth over the last several years, with an expected market valuation of over $1.7 billion by 2025, according to the Brightfield Group. Overall pet ownership is also increasing, due partly to the pandemic, with more than half of U.S. households having a pet dog or cat and 64% of CBD consumers are specifically buying CBD products for their pets because of the holistic benefits they provide. The global CBD pet market size was valued at USD 27.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2020 to 2027. The perceived benefits of cannabis, high awareness among pet owners, and consumers’ preference for natural pet supplements have led to an upsurge in the growth of this market.공시 • May 19Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/18/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 11Grapefruit USA, Inc. Launches New Affiliate Program in Conjunction with New E-Commerce StoreGrapefruit USA, Inc. announced its new Affiliate Program which will complement its new E-Commerce Store. The new Affiliate Program is designed to facilitate the ability of approved and authorized third party resellers with existing online retail platforms to market and sell Grapefruit’s THC-free hemp derived CBD Hourglass powered products.공시 • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Mar 16Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Now Available on Crown Genetics Mobile Retail Distribution PlatformGrapefruit USA, Inc. announced that its patented, disruptive Hourglass™ time release THC+ Cannabinoid delivery cream and full spectrum RSO cannabis oil are now available for purchase on Crown Genetics’ (“Crown”) retail delivery online platform in California under the “Wellness” section. As a result, customers who live in Los Angeles County can have Hourglass delivered to their home or office via the Crown delivery distribution system. The public will also be able to buy Hourglass™, as well as Grapefruit’s full spectrum RSO oil, at any of the over 250 California licensed retail dispensaries serviced by the Crown distribution system as soon as these products are delivered and stocked in these retail outlets. Hourglass™ and the RSO are currently available for retail purchase at the Apothecary 420 Dispensary in Sherman Oaks, California.공시 • Mar 09Grapefruit USA, Inc. Announces Resignation of John Hollister from the Board of DirectorsGrapefruit USA, Inc. announced that on February 26, 2021 John Hollister resigned from the Company's board of directors. Mr. Hollister's resignation was accepted by the Board.공시 • Mar 03Grapefruit USA, Inc. Signs Memorandum of Understanding with Canadian Partner to Form New Joint Venture Corporation to Manufacture and Distribute its Patented, Disruptive Hourglass THC/ Cannabinoid ProductsGrapefruit USA, Inc. signed a memorandum of understanding (the MOU) with a Canadian Partner which sets forth the general terms of their agreement to form a new joint venture corporation to manufacture and distribute the company’s patented, disruptive Hourglass THC/cannabinoid products, throughout the Commonwealth of Canada including on Canadian First Nation Lands. Under the terms of the MOU, products to be sold in Canada shall be manufactured in Canada in licensed facilities, and in some cases under appropriate framework on Canadian First Nations Land under license from the company by the joint venture, with the provision of technical know-how, lab staff and the patented Z-Pod by the company and provision of compliant Canadian-made THC/CBD distillates and terpenes by the Canadian Partner. Subject to certain, yet to be negotiated issues the joint venture shall be managed jointly by the company and the Canadian Partner and joint venture profits will generally be split 50%/50%, subject to certain exceptions. The Canadian Partner shall have exclusive rights with respect to sales of Hourglass products in Health Canada Permitted retail locations, and in First Nation’s Lands, from the formation of the joint venture with exclusive rights with respect to sales of Hourglass products throughout Canada for 180 days while the parties negotiate in good faith to establish unit sales minimums to support exclusivity.공시 • Feb 23Grapefruit USA, Inc. Secures Trademark Protection for the ‘Hourglass’ Name and LogoGrapefruit USA, Inc. announced that it has obtained California Trademark protection for Grapefruit’s patented disruptive Hourglass™ THC/Cannabinoid time-release delivery cream. The Hourglass™ name and logo are protected intellectual property rights of the Company which prevents all others operating in the Cannabis space from exploitation of such property. The Company also possesses common law, first-in-time, trademark protection to Hourglass™. The Company will obtain its Federal trademark protection when the Federal government legalizes cannabis, expected by many to be later this year.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 GPFT 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: GPFT 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Grapefruit USA 배당 수익률 vs 시장GPFT의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (GPFT)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Pharmaceuticals)2.2%분석가 예측 (GPFT) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 GPFT 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 GPFT 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 GPFT 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: GPFT 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/15 05:00종가2026/05/15 00:00수익2022/09/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Grapefruit USA, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Nov 16Grapefruit USA, Inc. announced delayed 10-Q filingOn 11/15/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 17Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/16/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/17/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 20Health Canada Approves NNCP for Grapefruit USA, Inc. Hourglass Time Release THC+CBD Delivery CreamGrapefruit USA, Inc. announced that its Notice of New Cannabis Product (“NNCP”), filed with Health Canada on Jan. 11, 2022, was approved by Health Canada on March 21, 2022, under NNCP ID No. NP-V2EHUWO907. As a result, Grapefruit is now authorized to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Approval of Grapefruit’s NNCP was a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. As a result of the Health Canada Hourglass™ NNCP approval, Grapefruit can sell Hourglass THC-infused products throughout both California and Canada, which have a combined population in excess of 75 million people. Grapefruit believes its Hourglass™ THC/CBD delivery cream is a truly disruptive technology that will fundamentally change the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without exposure to the dangers of smoking and/or orally ingesting THC, CBD and other cannabinoids. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass technology enables users, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass-based products work without the health risks from smoking or orally ingesting THC and CBD.
공시 • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2022, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 29Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc.Grapefruit USA, Inc. (OTCPK:GPFT) signed a Memorandum of Understanding to acquire Substantially All Assets of Diagnostic Lab Corporation, Inc. from Diagnostic Lab Corporation, Inc. on March 22, 2022. Grapefruit USA, Inc. (OTCPK:GPFT) will issue a to be agreed upon number of its common shares in consideration of the Acquisition. The transaction is subject to Due Diligence Review by Diagnostic Lab Corporation, Inc., signing of a binding Letter of Intent and a Definitive Agreement. The parties will sign a binding Letter of Intent on or before April15, 2022 and will close the transaction on or before September 1, 2022.
공시 • Mar 05Grapefruit USA, Inc. Updates on Hourglass Health Canada NNCP SubmissionGrapefruit USA, Inc. announced Notice of New Cannabis Product filed with Health Canada for its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets throughout Canada. Health Canada is the department of the federal government of Canada responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. On Feb. 18, 2022, Grapefruit received an inquiry from Health Canada about the composition of specific Hourglass ingredients. Grapefruit’s timely response to the inquiry was promptly accepted by Health Canada. Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology which has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and/or oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids.
공시 • Feb 24Grapefruit Usa, Inc. Announces CEO Bradley J. Yourist Has Been Elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’S Property Owners Association Board of DirectorsGrapefruit USA, Inc. announced that its Chief Executive Officer Bradley J. Yourist has been elected to the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park’s Property Owners Association Board of Directors for a one-year term, effective immediately.
공시 • Dec 07Grapefruit USA Announce Official Launch of Patented Time-Release, Hemp-Based CBD Topical Cream with Boosted Bioavailability, Made Possible by Its Proprietary Hourglass™ TechnologyGrapefruit USA, Inc. announced the official launch of the world’s first patented time-release, hemp-based CBD topical cream with boosted bioavailability, made possible by its proprietary Hourglass™ technology. Hourglass™ is a unique method for staggered and discreet topical delivery of CBD. The brand-new technology, developed by Grapefruit, leverages a proprietary process that involves the grinding of CBD into nano sized particles, substantially smaller than the width of a human hair, which allows for significantly higher bioavailability and absorption. The nano-particle technology enables anyone who wants to enjoy the incredible holistic benefits of CBD to do so, both immediately and over a sustained period of up to 8-10 hours, in a discreet and convenient manner. The micro-sized vessels called “Z-Pods™”, lodge deep into human pores and follicles, persisting there, before slowly releasing CBD over an extended time period, forming what Grapefruit has dubbed the “Patchless-Patch™” system.
공시 • Aug 18Grapefruit USA, Inc. announced delayed 10-Q filingOn 08/17/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jun 15Grapefruit Usa, Inc. Expands its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet TinctureGrapefruit USA, Inc. (‘GPFT,’ ‘Grapefruit’ or the ‘Company’) announced that it is expanding its hemp-based cannabidiol (‘CBD’) product line with a new U.S. Department of Agriculture (‘USDA’) certified CBD pet tincture targeting two of the most common dog and cat ailments – anxiety and joint pain. Grapefruit’s new Pet 300 mg CBD hemp-based tincture is derived from USDA Certified Organic hemp, grown only in the United States. The pet CBD industry has experienced significant growth over the last several years, with an expected market valuation of over $1.7 billion by 2025, according to the Brightfield Group. Overall pet ownership is also increasing, due partly to the pandemic, with more than half of U.S. households having a pet dog or cat and 64% of CBD consumers are specifically buying CBD products for their pets because of the holistic benefits they provide. The global CBD pet market size was valued at USD 27.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2020 to 2027. The perceived benefits of cannabis, high awareness among pet owners, and consumers’ preference for natural pet supplements have led to an upsurge in the growth of this market.
공시 • May 19Grapefruit USA, Inc. announced delayed 10-Q filingOn 05/18/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 11Grapefruit USA, Inc. Launches New Affiliate Program in Conjunction with New E-Commerce StoreGrapefruit USA, Inc. announced its new Affiliate Program which will complement its new E-Commerce Store. The new Affiliate Program is designed to facilitate the ability of approved and authorized third party resellers with existing online retail platforms to market and sell Grapefruit’s THC-free hemp derived CBD Hourglass powered products.
공시 • Apr 03Grapefruit USA, Inc. announced delayed annual 10-K filingOn 04/01/2021, Grapefruit USA, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Mar 16Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Now Available on Crown Genetics Mobile Retail Distribution PlatformGrapefruit USA, Inc. announced that its patented, disruptive Hourglass™ time release THC+ Cannabinoid delivery cream and full spectrum RSO cannabis oil are now available for purchase on Crown Genetics’ (“Crown”) retail delivery online platform in California under the “Wellness” section. As a result, customers who live in Los Angeles County can have Hourglass delivered to their home or office via the Crown delivery distribution system. The public will also be able to buy Hourglass™, as well as Grapefruit’s full spectrum RSO oil, at any of the over 250 California licensed retail dispensaries serviced by the Crown distribution system as soon as these products are delivered and stocked in these retail outlets. Hourglass™ and the RSO are currently available for retail purchase at the Apothecary 420 Dispensary in Sherman Oaks, California.
공시 • Mar 09Grapefruit USA, Inc. Announces Resignation of John Hollister from the Board of DirectorsGrapefruit USA, Inc. announced that on February 26, 2021 John Hollister resigned from the Company's board of directors. Mr. Hollister's resignation was accepted by the Board.
공시 • Mar 03Grapefruit USA, Inc. Signs Memorandum of Understanding with Canadian Partner to Form New Joint Venture Corporation to Manufacture and Distribute its Patented, Disruptive Hourglass THC/ Cannabinoid ProductsGrapefruit USA, Inc. signed a memorandum of understanding (the MOU) with a Canadian Partner which sets forth the general terms of their agreement to form a new joint venture corporation to manufacture and distribute the company’s patented, disruptive Hourglass THC/cannabinoid products, throughout the Commonwealth of Canada including on Canadian First Nation Lands. Under the terms of the MOU, products to be sold in Canada shall be manufactured in Canada in licensed facilities, and in some cases under appropriate framework on Canadian First Nations Land under license from the company by the joint venture, with the provision of technical know-how, lab staff and the patented Z-Pod by the company and provision of compliant Canadian-made THC/CBD distillates and terpenes by the Canadian Partner. Subject to certain, yet to be negotiated issues the joint venture shall be managed jointly by the company and the Canadian Partner and joint venture profits will generally be split 50%/50%, subject to certain exceptions. The Canadian Partner shall have exclusive rights with respect to sales of Hourglass products in Health Canada Permitted retail locations, and in First Nation’s Lands, from the formation of the joint venture with exclusive rights with respect to sales of Hourglass products throughout Canada for 180 days while the parties negotiate in good faith to establish unit sales minimums to support exclusivity.
공시 • Feb 23Grapefruit USA, Inc. Secures Trademark Protection for the ‘Hourglass’ Name and LogoGrapefruit USA, Inc. announced that it has obtained California Trademark protection for Grapefruit’s patented disruptive Hourglass™ THC/Cannabinoid time-release delivery cream. The Hourglass™ name and logo are protected intellectual property rights of the Company which prevents all others operating in the Cannabis space from exploitation of such property. The Company also possesses common law, first-in-time, trademark protection to Hourglass™. The Company will obtain its Federal trademark protection when the Federal government legalizes cannabis, expected by many to be later this year.